C07K 16/108
Orthomyxoviridae
Official title: Orthomyxoviridae (F), e.g. influenza virus
C07K16/108 (Orthomyxoviridae) appears on 427 US grants and 683 published applications in this corpus.
Search patents in C07K- Granted patents
- 427
- Published applications
- 683
- Assignees
- 313
- Inventors
- 1,124
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 2 |
| 2003 | 1 | 4 |
| 2004 | 1 | 3 |
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 1 | 4 |
| 2008 | 0 | 10 |
| 2009 | 1 | 12 |
| 2010 | 3 | 33 |
| 2011 | 9 | 38 |
| 2012 | 13 | 41 |
| 2013 | 20 | 33 |
| 2014 | 28 | 45 |
| 2015 | 30 | 37 |
| 2016 | 28 | 56 |
| 2017 | 34 | 47 |
| 2018 | 40 | 31 |
| 2019 | 42 | 42 |
| 2020 | 35 | 45 |
| 2021 | 22 | 35 |
| 2022 | 19 | 37 |
| 2023 | 24 | 38 |
| 2024 | 30 | 41 |
| 2025 | 23 | 29 |
| 2026 | 9 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Use of SARS-CoV-2 receptor binding motif (RBM)-reactive monoclonal antibodies to treat COVID-196 Oct 2026US 12,753,417 B2The Feinstein Institutes for Medical Research
- RNA encoding an antibody29 Sep 2026US 12,747,451 B2Cure Vac SE
- Method for selecting antibody fragments, recombinant antibodies produced therefrom, and uses thereof15 Sep 2026US 12,735,697 B2Academia Sinica
- Influenza virus encoding a truncated NS1 protein and a SARS-CoV receptor binding domain18 Aug 2026US 12,708,663 B2Vivaldi Biosciences Inc.
- Antibody for porcine reproductive and respiratory syndrome virus and uses thereof12 May 2026US 12,625,138 B2Novascope Biochips Inc.
- Asymmetric circular tandem repeat proteins1 Oct 2026US 2026/0297166 A1Seattle Children's Hospital d/b/a Seattle Children's Research Institute
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof17 Sep 2026US 2026/0274995 A1ModeX Therapeutics, Inc.
- Anti-toh1 antibodies and methods of use thereof3 Sep 2026US 2026/0258116 A1The Cleveland Clinic Foundation
- Methods of analyzing recombinant polyclonal proteins3 Sep 2026US 2026/0259221 A1GigaGen, Inc.
- Pan-neuraminidase inhibiting antibodies27 Aug 2026US 2026/0250365 A1Icahn School of Medicine at Mount Sinai
Most cited
By later US patents
- Process for the production of human mono-clonal antibodies92US 4,634,664 ASandoz Ltd. · 1987
- Constructs and libraries comprising antibody surrogate light chain sequences79US 8,114,967 B2Sea Lane Biotechnologies, LLC · 2012
- Method for identifying or shielding functional sites or epitopes of proteins that enter the exocytotic pathway of eukaryotic cells, the mutant proteins so produced and genes encoding said mutant proteins73US 5,041,376 ABoard of Regents, The University of Texas System · 1991
- Anti-human influenza virus antibody73US 5,589,174 ATakara Shuzo Co., Ltd. · 1996
- Anti-human influenza virus antibody70US 5,631,350 ATakara Shuzo Co., Ltd. · 1997